BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN

Reuters

03/12

March 12 (Reuters) - OrbusNeich Medical Group Holdings Ltd 6929.HK:

ORBUSNEICH MEDICAL GROUP HOLDINGS FY REVENUE USD 180.5 MILLION
FY PROFIT ATTRIBUTABLE $34.8 MILLION
FINAL DIVIDEND 12 HK CENTS PER SHARE
IN 2026, OVERSEAS REVENUE IS EXPECTED TO CONTINUE ITS STEADY GROWTH
ANTICIPATES REVENUE GROWTH WILL CONTINUE TO ACCELERATE IN 2026
WILL CONTINUE TO REVIEW DIVIDEND POLICY AND EXPLORE POSSIBILITY OF DISTRIBUTING INTERIM DIVIDENDS IN FUTURE.

Further company coverage: 6929.HK

((Reuters.Briefs@thomsonreuters.com;))

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2618713350"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618713350\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618713350?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-12 18:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618713350","market":"nz","top_or_hot":-1,"title":"BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN</title></head><body><p><span>March 12 (Reuters)</span><span> - </span>OrbusNeich Medical Group Holdings Ltd <span>6929.HK</span>:</p><ul><li><p>ORBUSNEICH MEDICAL GROUP HOLDINGS FY REVENUE USD 180.5 MILLION</p></li><li><p>FY PROFIT ATTRIBUTABLE $34.8 MILLION</p></li><li><p>FINAL DIVIDEND 12 HK CENTS PER SHARE</p></li><li><p>IN 2026, OVERSEAS REVENUE IS EXPECTED TO CONTINUE ITS STEADY GROWTH</p></li><li><p>ANTICIPATES REVENUE GROWTH WILL CONTINUE TO ACCELERATE IN 2026</p></li><li><p>WILL CONTINUE TO REVIEW DIVIDEND POLICY AND EXPLORE POSSIBILITY OF DISTRIBUTING INTERIM DIVIDENDS IN <a href=\"https://laohu8.com/S/FUTR.UK\">FUTURE</a>.</p></li></ul><p>Further company coverage: <span>6929.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-12 18:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLN</title></head><body><p><span>March 12 (Reuters)</span><span> - </span>OrbusNeich Medical Group Holdings Ltd <span>6929.HK</span>:</p><ul><li><p>ORBUSNEICH MEDICAL GROUP HOLDINGS FY REVENUE USD 180.5 MILLION</p></li><li><p>FY PROFIT ATTRIBUTABLE $34.8 MILLION</p></li><li><p>FINAL DIVIDEND 12 HK CENTS PER SHARE</p></li><li><p>IN 2026, OVERSEAS REVENUE IS EXPECTED TO CONTINUE ITS STEADY GROWTH</p></li><li><p>ANTICIPATES REVENUE GROWTH WILL CONTINUE TO ACCELERATE IN 2026</p></li><li><p>WILL CONTINUE TO REVIEW DIVIDEND POLICY AND EXPLORE POSSIBILITY OF DISTRIBUTING INTERIM DIVIDENDS IN <a href=\"https://laohu8.com/S/FUTR.UK\">FUTURE</a>.</p></li></ul><p>Further company coverage: <span>6929.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1222","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nPLX51382B:1","article_id":"2618713350","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618713350","pubTimestamp":1773311324,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLNMarch 12  - OrbusNeich Medical Group Holdings Ltd 6929.HK:ORBUSNEICH MEDICAL GROUP HOLDINGS FY REVENUE USD 180.5 MILLIONFY PROFIT ATTRIBUTABLE $34.8 MILLIONFINAL DIVIDEND 12 HK CENTS PER SHAREIN 2026, OVERSEAS REVENUE IS EXPECTED TO CONTINUE ITS STEADY GROWTHANTICIPATES REVENUE GROWTH WILL CONTINUE TO ACCELERATE IN 2026WILL CONTINUE TO REVIEW DIVIDEND POLICY AND EXPLORE POSSIBILITY OF DISTRIBUTING INTERIM DIVIDENDS IN FUTURE.Further company coverage: 6929.HK ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1222":"医疗保健用品","06929":"业聚医疗"},"translate_title":"简介-OrbusNeich医疗集团公布财年归属利润为3480万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06929":0.9},"content_text":"BRIEF-OrbusNeich Medical Group Posts FY Profit Attributable Of $34.8 MLNMarch 12 (Reuters) - OrbusNeich Medical Group Holdings Ltd 6929.HK:ORBUSNEICH MEDICAL GROUP HOLDINGS FY REVENUE USD 180.5 MILLIONFY PROFIT ATTRIBUTABLE $34.8 MILLIONFINAL DIVIDEND 12 HK CENTS PER SHAREIN 2026, OVERSEAS REVENUE IS EXPECTED TO CONTINUE ITS STEADY GROWTHANTICIPATES REVENUE GROWTH WILL CONTINUE TO ACCELERATE IN 2026WILL CONTINUE TO REVIEW DIVIDEND POLICY AND EXPLORE POSSIBILITY OF DISTRIBUTING INTERIM DIVIDENDS IN FUTURE.Further company coverage: 6929.HK ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}